ロード中...
Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial
OBJECTIVE: To determine whether treatment with recombinant human thrombomodulin (rhTM) increases survival among patients with severe septic-induced disseminated intravascular coagulation (DIC). DESIGN: Single-centre, open-label, randomised controlled trial. SETTING: Single tertiary hospital. PARTICI...
保存先:
| 出版年: | BMJ Open |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5223629/ https://ncbi.nlm.nih.gov/pubmed/28039291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-012850 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|